Abstract
Even though it is considering the most incident type of cancer among women, there are limited pharmacological options to reverse or restrain the disease and its recurrence. However, their acceptance among patients is low because of the adverse effects. This scenario highlights the need to develop new pharmacological and well accepted approaches that can be applied for prevention of breast…